Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simplified HTML structure and basic header/footer, replacing the previous study content and navigation with an access-restricted notice.
    Difference
    18%
    Check dated 2026-09-19T22:24:54.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    An NIH grant/contract note for 2015 was added and the revision label updated from v3.6.5 to v3.6.6, reflecting metadata/versioning updates rather than study content.
    Difference
    0.1%
    Check dated 2026-08-29T19:07:59.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - The page revision label updated from v3.6.4 to v3.6.5, representing a minor version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-08-08T09:43:49.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page’s revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new version of the page template.
    Difference
    0.0%
    Check dated 2026-07-25T07:37:52.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a backend/template update. No changes to the study text or user-facing elements are implied by this revision.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:00.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page content.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.